{"id":1192,"title":"Learn About Eliquis and Jardiance Price Is Dropping in 2026 And You Need To Know About It","slug":"learn-about-eliquis-and-jardiance-price-is-dropping-in-2026-and-you-need-to-know-about-it","lang":"en","description":"The cost of medications is a major concern for many, and changes are coming for two popular drugs: Eliquis and Jardiance. With potential cost reductions anticipated in 2026, it's essential to understand what these medicines cost and how these changes might impact you, especially in the context of Medicare and other potential cost challenges.","content":"

Understanding Eliquis Pricing

Eliquis (apixaban) is an oral factor Xa inhibitor used to prevent and treat blood clots and to reduce the risk of stroke in patients with atrial fibrillation. Current pricing varies, with the manufacturer’s list price at approximately $600 for a 30-day supply, while 2023 Medicare Part D analyses place the average list price closer to $521.

Beginning January 1, 2026, Medicare’s Drug Price Negotiation Program will establish a Maximum Fair Price (MFP) for Eliquis of about $231 for a 30-day supply. For Medicare beneficiaries, these negotiated prices are expected to reduce plan spending and may lower out-of-pocket costs. However, the exact copay will still depend on each Part D plan’s benefit design and formulary tiering.

Jardiance: A Closer Look at Costs

Jardiance (empagliflozin) is an FDA-approved oral medication used in adults with type 2 diabetes, heart failure, or chronic kidney disease. It helps control blood sugar levels while also reducing cardiovascular and renal risks.

As of 2023, the average list price for a 30-day supply of Jardiance was approximately $573, though actual costs vary depending on dosage and insurance coverage.

Under the first wave of Medicare’s drug price negotiation program, the negotiated Maximum Fair Price for Jardiance will drop to about $197 for a 30-day supply starting January 1, 2026. For individuals covered under Medicare Part D plans administered by the Centers for Medicare & Medicaid Services (CMS), this negotiated pricing could lower plan costs and potentially reduce out-of-pocket expenses for beneficiaries.

The Role of Medicare in Price Reductions

Medicare plays a pivotal role in reducing the cost of medications such as Eliquis and Jardiance. Understanding how these drugs are priced within the Medicare framework is essential for beneficiaries. The anticipated price reductions in 2026 could lead to meaningful savings for those enrolled in Medicare Part D, although the actual impact will depend on how negotiated prices are implemented across plans.

Beneficiaries should also consider how these changes may affect their overall healthcare budget. The interaction between Medicare policies and pharmaceutical pricing strategies will significantly influence the level of savings patients ultimately experience.

Potential Cost Challenges Ahead

While lower medication prices are promising, several cost challenges remain. Drug pricing is complex and influenced by factors such as supply chain logistics, insurance negotiations, and government regulations. As a result, reductions in list prices may not always translate directly into proportional reductions in out-of-pocket costs.

As 2026 approaches, it is important for patients to recognize that the impact of these changes may vary depending on individual insurance coverage and plan design. Staying informed about Medicare policy updates will be key to managing these potential challenges effectively.

Preparing for 2026 and Beyond

Patients should begin preparing for upcoming changes in medication costs. Understanding current pricing, future negotiated prices, and how these changes may affect personal healthcare expenses is essential for effective planning.

The evolving relationship between pharmaceutical manufacturers, insurance providers, and government agencies will continue to shape the future of drug pricing. By remaining proactive and informed, patients can better navigate these changes, maintain access to essential medications like Eliquis and Jardiance, and ensure that their healthcare remains both affordable and sustainable.

","type":"normal","status":"published","published_at":"2025-12-13T08:00:00.000000Z","rac":"Learn About Eliquis and Jardiance Price Is Dropping in 2026 And You Need To Know About It","keyword_set":null,"feature_media":"https://snwdata.info/media/posts/01KCAVM2PJSEH71MJKFYFMBA03.png","style":null,"channel":null,"campaign_id":null,"account_id":null,"ggid":null,"fbid":null,"traffic_type":null,"created_at":"2026-04-30T07:31:01.000000Z","updated_at":"2026-04-30T07:46:12.000000Z"}